The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

6 articles for J Weisner


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase Akt.EBI
TU Dortmund University
Covalent-Allosteric Inhibitors to Achieve Akt Isoform-Selectivity.EBI
TU Dortmund University and Drug Discovery Hub Dortmund (DDHD)
Akt Inhibitor Advancements: From Capivasertib Approval to Covalent-Allosteric Promises.EBI
TU Dortmund University and Drug Discovery Hub Dortmund (DDHD)
A high-throughput effector screen identifies a novel small molecule scaffold for inhibition of ten-eleven translocation dioxygenase 2.EBI
Tu Dortmund University
Targeting Her2-insYVMA with Covalent Inhibitors-A Focused Compound Screening and Structure-Based Design Approach.EBI
Tu Dortmund University
Substituted amino triazoles useful as human chitinase inhibitorsBDB
Oncoarendi Therapeutics